| 000 | 01824 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516123350.0 | ||
| 264 | 0 | _c20130708 | |
| 008 | 201307s 0 0 eng d | ||
| 022 | _a1873-7560 | ||
| 024 | 7 |
_a10.1016/j.eururo.2012.10.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSaylor, Philip J | |
| 245 | 0 | 0 |
_aNew and emerging therapies for bone metastases in genitourinary cancers. _h[electronic resource] |
| 260 |
_bEuropean urology _cFeb 2013 |
||
| 300 |
_a309-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBone Neoplasms _xsecondary |
| 650 | 0 | 4 |
_aCarcinoma _xsecondary |
| 650 | 0 | 4 | _aDenosumab |
| 650 | 0 | 4 |
_aDiphosphonates _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney Neoplasms _xpathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xpathology |
| 650 | 0 | 4 |
_aRANK Ligand _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xtherapeutic use |
| 650 | 0 | 4 |
_aRadium _xtherapeutic use |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xpathology |
| 650 | 0 | 4 |
_aUrogenital Neoplasms _xpathology |
| 650 | 0 | 4 | _aUrothelium |
| 650 | 0 | 4 | _aZoledronic Acid |
| 700 | 1 | _aArmstrong, Andrew J | |
| 700 | 1 | _aFizazi, Karim | |
| 700 | 1 | _aFreedland, Stephen | |
| 700 | 1 | _aSaad, Fred | |
| 700 | 1 | _aSmith, Matthew R | |
| 700 | 1 | _aTombal, Bertrand | |
| 700 | 1 | _aPienta, Kenneth | |
| 773 | 0 |
_tEuropean urology _gvol. 63 _gno. 2 _gp. 309-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.eururo.2012.10.007 _zAvailable from publisher's website |
| 999 |
_c22309822 _d22309822 |
||